Édith Beaulieu
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Peptidase Inhibition and Analysis
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
- Oncology 12
- Drug Transport and Resistance Mechanisms 8
- Epidemiology 12
- Influenza Virus Research Studies 12
- Respiratory viral infections research 8
- Co-authors
- Richard Béliveau (23 shared papers)Michel Demeule (6 shared papers)Denis Gingras (10 shared papers)Lucian Ghitescu (1 shared paper)Corey P. Mallett (12 shared papers)Dominique Boivin (5 shared papers)Sylvie Lamy (4 shared papers)Robert Moumdjian (2 shared papers)
- Journals
- Vaccine (3 papers)Thrombosis Research (3 papers)Biochemistry and Cell Biology (2 papers)Carcinogenesis (2 papers)npj Vaccines (2 papers)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
Édith Beaulieu
35 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Oncology 578
- Immunology and Allergy 125
- Cancer Research 303
- Biochemistry 76
- Transplantation 33
Countries citing papers authored by Édith Beaulieu
This map shows the geographic impact of Édith Beaulieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Édith Beaulieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Édith Beaulieu more than expected).
Fields of papers citing papers by Édith Beaulieu
This network shows the impact of papers produced by Édith Beaulieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Édith Beaulieu. The network helps show where Édith Beaulieu may publish in the future.
Co-authors
The 25 scholars most cited alongside Édith Beaulieu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 202 | |
| 2 | 2008 | 120 | |
| 3 | 1999 | 119 | |
| 4 | 2007 | 116 | |
| 5 | 1999 | 112 | |
| 6 | 2002 | 100 | |
| 7 | 2010 | 83 | |
| 8 | 2016 | 77 | |
| 9 | 2009 | 75 | |
| 10 | 1996 | 73 | |
| 11 | The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. | 2002 | 54 |
| 12 | 2011 | 50 | |
| 13 | The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis. | 2002 | 49 |
| 14 | 2008 | 46 | |
| 15 | 1999 | 42 | |
| 16 | 1998 | 38 | |
| 17 | 2008 | 36 | |
| 18 | 2015 | 28 | |
| 19 | 2008 | 25 | |
| 20 | 1995 | 25 |
About Édith Beaulieu
Édith Beaulieu is a scholar working on Oncology, Epidemiology, Molecular Biology, Cancer Research and Hematology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (12 papers), Protease and Inhibitor Mechanisms (8 papers), Drug Transport and Resistance Mechanisms (8 papers), Respiratory viral infections research (8 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Animal Disease Management and Epidemiology (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Oncology (578 citations), Immunology and Allergy (125 citations), Cancer Research (303 citations), Biochemistry (76 citations) and Transplantation (33 citations). Édith Beaulieu has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Richard Béliveau, Michel Demeule, Denis Gingras, Lucian Ghitescu, Corey P. Mallett, Dominique Boivin, Sylvie Lamy, Robert Moumdjian, Carine Nyalendo and Z. Kachra. Their work appears in journals such as Vaccine, Thrombosis Research, Biochemistry and Cell Biology, Carcinogenesis and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.